Mechanisms of HBV-Induced Innate Immunity
乙型肝炎病毒诱导的先天免疫机制
基本信息
- 批准号:9513990
- 负责人:
- 金额:$ 38.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-23 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntiviral AgentsApoptosisApoptoticApplications GrantsAttenuatedCell DeathCell MaintenanceChronicChronic HepatitisChronic Hepatitis BComplexDataDynaminEventExcisionFibrosisGene ExpressionGenesGoalsHepatitis BHepatitis B VirusHomeostasisHumanImmuneImmune signalingInjuryInnate Immune ResponseInterferonsInvestigationLeadLinkLiver MitochondriaLiver diseasesLysineMaintenanceMediatingMediator of activation proteinMetabolicMitochondriaMolecularNatural ImmunityOxidative StressPINK1 geneParkinson DiseasePathogenesisPathway interactionsPhosphorylationPhosphotransferasesPhysiologicalPlayPrimary carcinoma of the liver cellsProcessProductionProteinsPublishingReceptor SignalingRisk FactorsRoleSignal TransductionSignaling MoleculeSignaling ProteinTNF receptor-associated factor 3TretinoinUbiquitinationVirus DiseasesWorkchronic infectionchronic liver injurycytochrome cinsightliver injurymitochondrial autophagynovelparkin gene/proteinprotein functionrecruittherapeutic targetubiquitin-protein ligase
项目摘要
Project Summary/Abstract
Chronic Hepatitis B virus infections affect about 350 million people worldwide and constitute a
significant risk factor for fibrosis and hepatocellular carcinoma (HCC). HBV alters mitochondrial
dynamics. HBV has been shown to induce autophagy of mitochondria (Mitophagy) as evidenced by
Parkin translocation to mitochondria. We propose to investigate a possible link between mitochondrial
dynamics induced by HBV and innate immunity. HBV cripples host innate immunity to maintain
chronic persistent infection. Here, we propose to investigate the molecular mechanisms of HBV-
induced suppression of innate immune signaling from mitochondrial platform. The key player in this
process is a mitochondrial antiviral signaling protein (MAVS). There is sufficient supporting
information, which shows that Parkin, an E3 ubiquitin ligase, interacts with MAVS on the mitochondria
and that Parkin causes the ubiquitination of MAVS. These investigations will elucidate how MAVS is
targeted by Parkin in a supracomplex and affects downstream antiviral signaling of interferon
synthesis. These interactions and ubiquitinations eventually cripple innate immunity. These studies
will provide unique insights into molecular mechanisms of HBV-induced mitochondrial dynamics and
its effects on altering host innate immune response and open new avenues of investigations in the
elucidation of innate immune pathways.
项目总结/摘要
慢性B型肝炎病毒感染影响全世界约3.5亿人,并构成一个全球性的疾病。
纤维化和肝细胞癌(HCC)的重要危险因素。HBV改变线粒体
动力学HBV已显示诱导线粒体的自噬(线粒体自噬),如以下所证明的:
帕金易位到线粒体。我们建议调查线粒体和线粒体之间的可能联系,
HBV和先天免疫诱导的动力学。HBV削弱宿主的先天免疫力,
慢性持续性感染在这里,我们建议研究HBV的分子机制-
诱导抑制来自线粒体平台的先天免疫信号传导。这件事的关键人物
该过程是线粒体抗病毒信号蛋白(MAVS)。有足够的支持
信息,这表明Parkin,一种E3泛素连接酶,与线粒体上的MAVS相互作用
帕金导致了MAVS的泛素化。这些调查将阐明MAVS是如何
在超复合体中被帕金靶向并影响干扰素的下游抗病毒信号传导
合成.这些相互作用和泛素化最终削弱了先天免疫。这些研究
将为HBV诱导的线粒体动力学的分子机制提供独特的见解,
它对改变宿主先天免疫反应的影响,并开辟了新的研究途径,
阐明先天免疫途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEEM SIDDIQUI其他文献
ALEEM SIDDIQUI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEEM SIDDIQUI', 18)}}的其他基金
Epitranscriptomic regulation of HBV gene expression
HBV基因表达的表观转录组调控
- 批准号:
10092086 - 财政年份:2019
- 资助金额:
$ 38.75万 - 项目类别:
Epitranscriptomic regulation of HBV gene expression
HBV基因表达的表观转录组调控
- 批准号:
10361391 - 财政年份:2019
- 资助金额:
$ 38.75万 - 项目类别:
Epitranscriptomic regulation of HBV gene expression
HBV基因表达的表观转录组调控
- 批准号:
10569036 - 财政年份:2019
- 资助金额:
$ 38.75万 - 项目类别:
2016 Internatinal Meeting o the Molecular Biology of Hepatitis B Viruses
2016乙型肝炎病毒分子生物学国际会议
- 批准号:
9124150 - 财政年份:2016
- 资助金额:
$ 38.75万 - 项目类别:
Intervention of HBV DNA synthesis and transcription
干预 HBV DNA 合成和转录
- 批准号:
8511268 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
Intervention of HBV DNA synthesis and transcription
干预 HBV DNA 合成和转录
- 批准号:
8731176 - 财政年份:2013
- 资助金额:
$ 38.75万 - 项目类别:
Role of Lipids in Hepatitis C Virus Maturation
脂质在丙型肝炎病毒成熟中的作用
- 批准号:
8286215 - 财政年份:2010
- 资助金额:
$ 38.75万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 38.75万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 38.75万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 38.75万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 38.75万 - 项目类别:














{{item.name}}会员




